Home/Filings/4/0001209191-22-004068
4//SEC Filing

Mattsson Jan 4

Accession 0001209191-22-004068

CIK 0001322505other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:54 PM ET

Size

5.2 KB

Accession

0001209191-22-004068

Insider Transaction Report

Form 4
Period: 2022-01-18
Mattsson Jan
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2022-01-18+21,60059,174 total
Footnotes (2)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.
  • [F2]Represents 32,074 shares of common stock and 27,100 restricted stock units.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1
  • filerCIK 0001687436

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:54 PM ET
Size
5.2 KB